Breaking News

Scorpius BioManufacturing to Support Preclinical Program

Key element of the project is Scorpius’ specialized analytical and process development laboratories.

NightHawk Biosciences, a contract development and manufacturing organization (CDMO), reported that its Scorpius BioManufacturing subsidiary has been awarded a project to support a preclinical program for a U.S. based biotech company. The initial project value exceeds one million dollars, with the potential to exceed several million dollars over the next two years. Jeff Wolf, CEO of NightHawk, said, “We are pleased to have been awarded this competitive bid due to the versatility of our biologi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters